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Background. Squamous cell carcinoma of the gallbladder is a rare disease with symptoms developing late in its course, so that it
often presents as an aggressive tumor with a poor prognosis. Case report. We describe a 58-year-old male with a 5-week history of
hypodynamia. He was found to have squamous cell carcinoma of the gallbladder with liver invasion and lymph node metastases.
He underwent treatment with 3-dimensional conformal radiation therapy (CRT). A follow-up computer tomography (CT) scan
showed complete tumor remission 2 months after the completion of CRT. The patient survived for 14 months after the end of
treatment and died of multiple liver metastases. Conclusion. The eﬃcacy of radiotherapy in this case is encouraging and suggests a
potential role for such therapy in similar cases. The beneﬁt in terms of survival warrants further study.
1.Background
Primary carcinoma of the gallbladder is the ﬁfth most
common malignancy of the digestive tract [1]. Squamous
cell carcinoma, however, accounts for less than 3.93%
of gallbladder cancers in China [2]. Symptoms generally
develop late in the course of the disease, by which time the
malignancy is aggressive and carries a poor prognosis. We
report a case of advanced stage squamous cell carcinoma of
the gallbladder that acquired complete tumor remission 2
months after the completion of conformal radiation therapy
(CRT).
2.CaseReport
A 58-year-old male was admitted to the local hospital
with hypodynamia for 5 weeks. Physical examination was
unremarkable, but ultrasound examination showed liver and
gallbladder space-occupying lesions. Then an abdominal
computer tomography (CT) scan was recommended and
showed a tumor involving the gallbladder and the surround-
ing liver tissue, with possible portal lymph node metas-
tases and gallstones (Figure 1). For further diagnosis and
treatment, the patient was referred to our hospital. Physical
examination was still unremarkable, the Karnofsky perfor-
mance status (KPS) score was 90. A percutaneous biopsy was
performed with ultrasound guidance, and the pathological
diagnosis was squamous cell carcinoma. The pathologic
diﬀerentiation was grade II (Figure 2). Laboratory tests
showedthefollowing:redbloodcells4.5×109/L,hemoglobin
153g/L, white blood cells 5.2 × 109/L, Neutrophils 58.2%,
platelets 211 × 109/L, total bilirubin 10.4mmol/L, ala-
nine aminotransferase 24U/L, aspartate aminotransferase
31U/L, alkaline phosphatase 71U/L, α-fetoprotein (AFP)
1.8μg/L, carbohydrate antigen 19.9 (CA19.9) 8.5U/L, and
carcinoembryonic antigen (CEA) 4.56U/mL. According to
the CT, the surgeons ﬁgured that the tumor had lymph
node metastases, which involved portal vein lymph node,
inferior vena caval lymph node, and peripancreatic lymph
node. They considered that the tumor was unresectable. The
patient wasrecommendedtoreceiveconformalradiotherapy
due to consideration of the advanced nature of the disease.
3. Radiotherapy
The patient provided written informed consent regarding
treatment. No systemic chemotherapy was added during2 Case Reports in Medicine
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Figure 1: CT sections showing contours before radiotherapy. Radiation ports encompassed (a-b) regions of the liver involved by the
gallbladdertumorand(c-d)carcinomalocatedattheneckofthegallbladder.GTV54andCTV40havebeenshownintheslice.Abbreviation:
CTV: clinical target volume with pink lines; GTV: gross tumor volume with red lines.
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Figure 2: Micrographs of the squamous cell carcinoma of the gallbladder. (a) A liver biopsy showing squamous cell carcinoma with
intermediate diﬀerentiation under low power magniﬁcation (low power ﬁeld), and (b) a squamatoid pearl (black arrow) under high power
magniﬁcation.
radiotherapy. He underwent three-dimensional (3D) CRT
with limited-ﬁeld external beam radiation using a linear
accelerator with 15 megavoltage photons at an outpatient
clinic. For radiotherapy planning, the patient underwent
a CT scan in the supine position with both arms raised
above the head. The CT images were transferred to a 3D
CRT planning system (Pinnacle 7.6C). The gross target
volume included the gallbladder tumor, involved liver tissue,
and abnormally enlarged portal lymph nodes. The clinical
target volume included the gross target volume and the
peripancreatic and celiac trunk lymph nodes, which were
at risk for metastases. The planning treatment volumeCase Reports in Medicine 3
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Figure 3: Postradiation CT scans corresponding to the sections in Figure 1. The region of low attenuation in the liver (arrows) corresponded
to the treatment volume at 2 months after completion of 3D CRT. The tumor appears to have a complete response to 3D CRT.
included the clinical target volume and 0.7cm margins for
geometric uncertainties. The treatment portals encompassed
theplanning treatmentvolumeplus0.7cmineachdirection.
Dose-volume histograms of the planning treatment volume,
kidneys, liver, and spinal cord were necessary to select the
optimal dose distribution plan. Coverage of 99.9% of the
planning treatment volume by the 95% isodose line was
required. The clinical target volume was subject to 40Gy,
with 14Gy delivered to the gross tumor volume through
reducedﬁelds.Thedosewasinfractionsof2.0Gy,oncedaily,
ﬁ v et i m e sp e rw e e kf o r5w e e k s .
4. Result
Duringtheentireperiodofradiationtherapy,physicalexam-
ination, routine blood tests, and serum biochemistry tests
were performed once a week a n dr e m a i n e dn o r m a l .T h e
patient’s hypodynamia was relieved after completion of
radiotherapy. The tumor marker levels were similar before
and after treatment and considered normal (after treatment:
AFP 2.1ng/mL, CA19.9 7.9U/mL, CEA 4.1U/mL).
The patient was advised to return for follow-up 6 weeks
after completion of the radiotherapy. Response to radiother-
apy was evaluated at that time with an enhanced abdominal
CT (Figure 3). CT showed that the tumor appeared to have
a complete response to 3D CRT. A chest radiograph and
wholebodybonescanshowednoevidenceofmetastasis.The
patient was monitored every 3 months thereafter, and the
abdominalCTremainedunremarkableuntil13monthsafter
completionofradiotherapy.Atthattime,multiplemetastatic
lesions were found on CT. Two months later, the patient died
of liver failure induced by intrahepatic lesions. The survival
period was 15 months from initiation of radiation therapy to
death.
5. Discussion and Conclusion
Gallbladder cancer is the most common malignant originat-
ing from biliary tract and represents approximately 8.4% of
the estimated cases of hepatobiliary cancers diagnosed in the
USA[3].Squamouscellcarcinomaofthegallbladderisarare
disease, accounting for 0.5%–12.7% of all malignant tumors
of the gallbladder [4]. This malignancy is an aggressive and
late symptomatic disease and most patients are treated at an
advanced stage with a poor prognosis.
The only potentially curative therapy for gallbladder
carcinoma is surgical resection. Unfortunately, most patients
with this type of cancer have unresectable disease—only4 Case Reports in Medicine
10%–30% of patients are candidates for surgery at presenta-
tion.Atpresent,notherapyisdeﬁnedforunresectablecancer
of the gallbladder, especially for squamous cell carcinoma.
Reports on the eﬃcacy of radiotherapy for gallbladder car-
cinoma are disappointing; most series have a small number
of patients and results regarding survival are inconsistent.
However, one study indicated that external beam radiother-
apy, as an adjuvant to surgical treatment, has some beneﬁcial
eﬀect on survival [5]. Radiotherapy may also be used in
palliative management of advanced gallbladder carcinoma.
We found no reports on radiotherapy for squamous cell
carcinoma of gallbladder. In this case, the patient was treated
with radiotherapy alone. CT scans showed complete tumor
remission from 2 months to 13 months after treatment. This
is encouraging evidence for the eﬃcacy of radiotherapy for
squamous cell carcinoma of the gallbladder, suggesting a
possible role in treatment. However, the beneﬁt in survival
must be studied further. Ultimately, our patient died of liver
failure due to intrahepatic metastases. Perhaps the addition
of chemotherapy to radiotherapy may have inﬂuenced the
outcome.
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